<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head><body style="">
<div>
Dear Elaine,
</div>
<div>
I followed the steps to save a ligand in .mol2 file but the mol2 format file after saving is not opening in the chimera even after adding the charges.
</div>
<div>
Please help me with what steps should i follow.
</div>
<div>
</div>
<div>
Thank You
</div>
<div>
Regards
</div>
<div>
Gayatri
</div>
<div>
<br/>On June 21, 2022 at 1:47 AM Elaine Meng <meng@cgl.ucsf.edu> wrote:
<br/>> Hi Gayatri,
<br/>> There is a Dock Prep tool that does all this. Menu: Tools... Structure Editing... Dock Prep
<br/>> <https://www.rbvi.ucsf.edu/chimera/docs/ContributedSoftware/dockprep/dockprep.html>
<br/>>
<br/>> If you mean that you have too many files to do individually with the graphical interface, however, you may need to figure out how do it with Chimera commands instead. See commands "open" to open the ligand file, "addh" to add hydrogens, "addcharge" to assign partial charges (and maybe other commands depending on what you mean by prepare) and"write" to save Mol2.
<br/>> <https://www.rbvi.ucsf.edu/chimera/docs/UsersGuide/midas/open.html>
<br/>> <https://www.rbvi.ucsf.edu/chimera/docs/UsersGuide/midas/addh.html>
<br/>> <https://www.rbvi.ucsf.edu/chimera/docs/UsersGuide/midas/addcharge.html>
<br/>> <https://www.rbvi.ucsf.edu/chimera/docs/UsersGuide/midas/write.html>
<br/>>
<br/>> You should first try entering those individual commands in the Command Line one by one to figure out exactly what options you want for each ligand. After you know what commands and options you want to use for each ligand, then you can put a python script around it to loop through multiple files as described here
<br/>> <https://www.rbvi.ucsf.edu/chimera/docs/ProgrammersGuide/basicPrimer.html>
<br/>>
<br/>> I hope this helps,
<br/>> Elaine
<br/>> -----
<br/>> Elaine C. Meng, Ph.D.
<br/>> UCSF Chimera(X) team
<br/>> Department of Pharmaceutical Chemistry
<br/>> University of California, San Francisco
<br/>>
<br/>> > On Jun 20, 2022, at 4:37 AM, ngayatri via Chimera-dev <chimera-dev@cgl.ucsf.edu> wrote:
<br/>> >
<br/>> > Dear Chimera Team,
<br/>> > I am trying to prepare separate ligand file and saving it in the .mol2 file. So if you could help with script or the approach would be grateful.
<br/>> > Thank You
<br/>> > Regards
<br/>> > Gayatri
<br/>>
<br/>>
<br/>>
<br/>> For assimilation and dissemination of knowledge, visit cakes.cdac.in
<br/>>
<br/>>
<br/>> ------------------------------------------------------------------------------------------------------------
<br/>> [ C-DAC is on Social-Media too. Kindly follow us at:
<br/>> Facebook: https://www.facebook.com/CDACINDIA & Twitter: @cdacindia ]
<br/>>
<br/>> This e-mail is for the sole use of the intended recipient(s) and may
<br/>> contain confidential and privileged information. If you are not the
<br/>> intended recipient, please contact the sender by reply e-mail and destroy
<br/>> all copies and the original message. Any unauthorized review, use,
<br/>> disclosure, dissemination, forwarding, printing or copying of this email
<br/>> is strictly prohibited and appropriate legal action will be taken.
<br/>> ------------------------------------------------------------------------------------------------------------
<br/>>
<br/>>
</div>
<br />------------------------------------------------------------------------------------------------------------
<br />[ C-DAC is on Social-Media too. Kindly follow us at:
<br />Facebook: https://www.facebook.com/CDACINDIA & Twitter: @cdacindia ]
<br />
<br />This e-mail is for the sole use of the intended recipient(s) and may
<br />contain confidential and privileged information. If you are not the
<br />intended recipient, please contact the sender by reply e-mail and destroy
<br />all copies and the original message. Any unauthorized review, use,
<br />disclosure, dissemination, forwarding, printing or copying of this email
<br />is strictly prohibited and appropriate legal action will be taken.
<br />------------------------------------------------------------------------------------------------------------
</body></html>